Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents.

Fillenbaum GG, Landerman LR, Blazer DG, Saunders AM, Harris TB, Launer LJ.

J Am Geriatr Soc. 2001 Sep;49(9):1148-55.

PMID:
11559372
2.

The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults.

Blazer DG, Fillenbaum G, Burchett B.

J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M785-9.

PMID:
11723155
3.

Relationship of race/ethnicity and blood pressure to change in cognitive function.

Bohannon AD, Fillenbaum GG, Pieper CF, Hanlon JT, Blazer DG.

J Am Geriatr Soc. 2002 Mar;50(3):424-9.

PMID:
11943035
4.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
5.
6.

Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults.

Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG.

Gerontology. 2009;55(1):32-40. doi: 10.1159/000137666. Epub 2008 Jun 5.

PMID:
18525196
7.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
8.

Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.

Swan GE, Lessov-Schlaggar CN, Carmelli D, Schellenberg GD, La Rue A.

J Geriatr Psychiatry Neurol. 2005 Dec;18(4):196-201.

PMID:
16306239
9.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
10.

APOE genotype and cognitive decline in a middle-aged cohort.

Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E; Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Neurology. 2005 Jan 25;64(2):268-76.

PMID:
15668424
11.

Apolipoprotein E genotype and lifetime cognitive decline.

Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG.

Int Psychogeriatr. 2008 Feb;20(1):109-23. Epub 2007 Aug 22.

PMID:
17711604
12.

Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?

Small BJ, Graves AB, McEvoy CL, Crawford FC, Mullan M, Mortimer JA.

Neurology. 2000 Jun 13;54(11):2082-8.

PMID:
10851367
13.

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr.

J Am Geriatr Soc. 1998 Dec;46(12):1493-8.

PMID:
9848808
14.
15.

Lower cognitive performance of older football players possessing apolipoprotein E epsilon4.

Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR.

Neurosurgery. 2000 Sep;47(3):651-7; discussion 657-8.

PMID:
10981753
16.

Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.

Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues JF.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):794-7.

17.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
18.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
19.

APOE epsilon4 and low cholesterol as risks for depression in a biracial elderly community sample.

Blazer DG, Burchett BB, Fillenbaum GG.

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):515-20.

PMID:
12213685
20.

Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents.

Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr.

Gerontologist. 2002 Jun;42(3):381-6.

PMID:
12040140
Items per page

Supplemental Content

Write to the Help Desk